Efficacy of conversion to sirolimus in posttransplantation Kaposi's sarcoma (Q36357244)

13 August 2017

Efficacy of conversion to sirolimus in posttransplantation Kaposi's sarcoma (English)

1 reference

13 August 2017

1 reference

José-Vicente Torregrosa

object named as

Torregrosa JV

8

0 references

author name string

Gutiérrez-Dalmau A

1

1 reference

13 August 2017

Sánchez-Fructuoso A

2

1 reference

13 August 2017

Sanz-Guajardo A

3

1 reference

13 August 2017

Mazuecos A

4

1 reference

13 August 2017

Franco A

5

1 reference

13 August 2017

Rial MC

6

1 reference

13 August 2017

Iranzo P

7

1 reference

13 August 2017

Oppenheimer F

9

1 reference

13 August 2017

Campistol JM

10

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

Transplantation Proceedings

13 August 2017

1 reference

13 August 2017

37

1 reference

13 August 2017

9

1 reference

13 August 2017

3836-3838

1 reference

Initiation of angiogenic Kaposi's sarcoma lesions

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.076

Renal transplantation exposes patients with previous Kaposi's sarcoma to a high risk of recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.076

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.076

Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.076

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.076

Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.076

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.076

Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.076

Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.076

Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.076

Conversion to sirolimus in solid organ transplantation: a Single-Center experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.076

Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.076

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRANSPROCEED.2005.10.076

1 reference

release_wu5cvvcanjhw7di4zmpmrcn4wi

13 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wu5cvvcanjhw7di4zmpmrcn4wi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference